AmerAsia Report Identifies Opportunities in China’s $ 300+ Billion Healthcare Industry
New York, NY (PRWEB) May 04, 2011
AmerAsia Capital Partners, LLC (“AmerAsia”) (http://www.amerasiagroup.com), a U.S.-Asia focused financial and strategic advisory firm, has released its report on the China Healthcare Industry. The report examines the key factors that are changing China’s healthcare sector in fundamental and unprecedented ways. An in-depth analysis of Chinese healthcare firms from a capital markets perspective and selected profiles of U.S. listed Chinese healthcare companies are included.
Key Highlights
Aligning major growth drivers are expected to sustain and potentially accelerate over this decade the impressive 20+ percent top-line growth of China’s USD 300+ billion healthcare industry.
By 2020, China’s healthcare industry is forecast to be close to becoming the world’s largest as the effect of socioeconomic forces, healthcare reform, industry restructuring and government efforts to foster technological advances converge to yield impressive results.
Structural changes are altering the industry landscape irrevocably and can provide unprecedented bottom line opportunities for pitfall savvy investors.
The authors believe U.S. listed China healthcare stocks are discounted in relation to their peers in Hong Kong and mainland China despite comparable fundamentals.
$300+, AmerAsia, Billion, Chinas, Healthcare, Identifies, Industry, Opportunities, Report